UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 9

of 'Chemotherapy in castration-resistant prostate cancer'

9
TI
Docetaxel and prednisone with or without lenalidomide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer (MAINSAIL): a randomised, double-blind, placebo-controlled phase 3 trial
AU
Petrylak D, Vogelzang N, Budnik N, et al
SO
Lancet Oncol. 2015;
 
AD